In both instances, the anti-cancer effect of GIP combined or conjugated to the chemotherapy drug was enhanced in T47D breast cancer and glioblastoma cells; furthermore, it may be possible that drug resistance to chemoagents could be bypassed. The gene discussed is GIP; the disease is cancer.